Sphingolipids and HSC fitness: enigma no more No … ← Boyraz B, Bellomo CM, Fleming MD, Cutler CS, Agarwal S. A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding. Blood. 2016;128(16):2089-2092 Gemtuzumab ozogamicin in AML: the next chapter →